In the present study, we provide further evidence that Met protein is highly expressed in papillary carcinoma cells, whereas it is absent or poorly expressed in normal thyroid follicles; moreover, we demonstrate for the first time that the different patterns of expression are not due to an altered methylation status of the MET promoter. The gene discussed is MET; the disease is papillary carcinoma.